Biomax Informatics Investing Big to Develop a Knowledge Solution for Mental Health

Biomax Informatics AG will invest nearly 1 million Euro over the next 4 years to transfer its successful systems medicine approach from respiratory and chronic diseases to mental health. The European Commission is co-financing this step with €650,000 as part of the METSY project. In the project, Biomax will provide the knowledge management platform and data integration for consortium partners from industry, research and clinics who are searching for associations between psychotic disorders, lipid metabolism and metabolism-related diseases such as obesity and diabetes.

Biomax will provide their BioXM™ Knowledge Management Environment to integrate and explore existing knowledge sources about brain structure and function, extend them with information about psychosis and genetic factors derived from the BioLT™ literature-mining software, and combine them with data generated within the METSY project itself including brain imaging (combined MRI and PET), metabolite profiling, and clinical data from approximately 500 patients recruited at four sites in Spain, the United Kingdom and Finland.

The resulting semantic network of psychosis-specific knowledge - generated from associations between structures, functions and molecules (genes, proteins, metabolites, etc.) - can be overlaid with patient-specific data. The standardization of information and data provided by the BioXM system enables algorithmic analysis and fosters collaboration with external, large-scale brain imaging and systems medicine initiatives. In particular, the METSY partners will use network inference to identify and evaluate multi-modal blood and neuroimaging biomarkers that could be used to predict and monitor psychotic disorders like schizophrenia in the context of metabolic diseases. If specific disease-associated patterns are detected in the project, the network can be further explored for potential explanations. After validation, the knowledge base can be used to build a decision support system to bring the results directly into clinical practice.

About METSY
METSY is a European consortium studying the links between psychotic disorders, lipid metabolism and metabolic co-morbidities such as metabolic syndrome and diabetes. The consortium aims to develop neuroimaging and bioinformatics tools to identify possible diagnostic biomarkers of psychosis.

Funded in part by the EU's Seventh Framework Programme, which provided ~€4.23 million of the €5.94 million total budget, the METSY consortium involves seven members who provide the remainder of the funding: VTT Technical Research Center of Finland, University of Turku, Finland's National Institute for Health and Welfare, Kings College London, Madrid Health Service, Philips Research and Biomax Informatics.

About Biomax Informatics AG
Biomax Informatics AG is a leader in the development of computational solutions for the life sciences. Biomax provides the BioXM™ Knowledge Management Environment and other computational solutions, including the Viscovery® data-mining technology, for better decision making and knowledge management in biomarker identification, patient stratification and targeted medicine.

Most Popular Now

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...